Chiranjibi Chhotaray

570 total citations
14 papers, 399 citations indexed

About

Chiranjibi Chhotaray is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Chiranjibi Chhotaray has authored 14 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Chiranjibi Chhotaray's work include Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (13 papers) and Cancer therapeutics and mechanisms (4 papers). Chiranjibi Chhotaray is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (13 papers) and Cancer therapeutics and mechanisms (4 papers). Chiranjibi Chhotaray collaborates with scholars based in China, Hong Kong and Pakistan. Chiranjibi Chhotaray's co-authors include H. M. Adnan Hameed, Tianyu Zhang, Md. Mahmudul Islam, Shouyong Tan, Yaoju Tan, Xinjie Li, Wing Wai Yew, Changwei Wang, Jianxiong Liu and Yang Liu and has published in prestigious journals such as Nature Communications, Frontiers in Microbiology and Clinical Microbiology and Infection.

In The Last Decade

Chiranjibi Chhotaray

14 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiranjibi Chhotaray China 11 280 194 174 74 48 14 399
Ameeruddin Nusrath Unissa India 9 273 1.0× 194 1.0× 159 0.9× 67 0.9× 65 1.4× 18 394
Pedro E. A. da Silva Brazil 6 330 1.2× 254 1.3× 166 1.0× 72 1.0× 76 1.6× 9 463
H. M. Adnan Hameed China 13 354 1.3× 250 1.3× 259 1.5× 81 1.1× 61 1.3× 29 532
Jan Madacki France 11 288 1.0× 186 1.0× 210 1.2× 165 2.2× 38 0.8× 14 486
Manju Yasoda Krishnan India 13 250 0.9× 212 1.1× 197 1.1× 58 0.8× 50 1.0× 25 434
Sarah E. M. Born United States 5 367 1.3× 272 1.4× 277 1.6× 62 0.8× 38 0.8× 7 516
Julie V. Early United States 14 289 1.0× 217 1.1× 210 1.2× 173 2.3× 32 0.7× 27 534
Norio Doi Japan 10 256 0.9× 199 1.0× 157 0.9× 65 0.9× 53 1.1× 20 389
Suresh B. Lakshminarayana Singapore 12 333 1.2× 216 1.1× 196 1.1× 110 1.5× 39 0.8× 15 573
Shao-Gang Li United States 6 158 0.6× 128 0.7× 115 0.7× 64 0.9× 39 0.8× 6 293

Countries citing papers authored by Chiranjibi Chhotaray

Since Specialization
Citations

This map shows the geographic impact of Chiranjibi Chhotaray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiranjibi Chhotaray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiranjibi Chhotaray more than expected).

Fields of papers citing papers by Chiranjibi Chhotaray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiranjibi Chhotaray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiranjibi Chhotaray. The network helps show where Chiranjibi Chhotaray may publish in the future.

Co-authorship network of co-authors of Chiranjibi Chhotaray

This figure shows the co-authorship network connecting the top 25 collaborators of Chiranjibi Chhotaray. A scholar is included among the top collaborators of Chiranjibi Chhotaray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiranjibi Chhotaray. Chiranjibi Chhotaray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Islam, Md. Mahmudul, Md Shah Alam, Xiaogang Li, et al.. (2024). Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis. Frontiers in Medicine. 10. 1304857–1304857. 6 indexed citations
2.
Islam, Md. Mahmudul, Yaoju Tan, H. M. Adnan Hameed, et al.. (2020). Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. Microbial Drug Resistance. 26(7). 766–775. 12 indexed citations
3.
Hameed, H. M. Adnan, Yaoju Tan, Md. Mahmudul Islam, et al.. (2020). <p>Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant <em>Mycobacterium tuberculosis</em> Clinical Isolates in Southern China</p>. Infection and Drug Resistance. Volume 13. 217–227. 20 indexed citations
4.
Islam, Md. Mahmudul, Yaoju Tan, H. M. Adnan Hameed, et al.. (2020). Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China. Journal of Global Antimicrobial Resistance. 22. 290–295. 13 indexed citations
5.
Chhotaray, Chiranjibi, Shuai Wang, Yaoju Tan, et al.. (2019). Comparative Analysis of Whole-Genome and Methylome Profiles of a Smooth and a Rough Mycobacterium abscessus Clinical Strain. G3 Genes Genomes Genetics. 10(1). 13–22. 17 indexed citations
6.
Hameed, H. M. Adnan, Yaoju Tan, Md. Mahmudul Islam, et al.. (2019). Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China. Journal of Thoracic Disease. 11(11). 4613–4625. 21 indexed citations
7.
Liu, Yang, Yamin Gao, Jianxiong Liu, et al.. (2019). The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model. Nature Communications. 10(1). 524–524. 46 indexed citations
8.
Islam, Md. Mahmudul, Yi Tan, H. M. Adnan Hameed, et al.. (2018). Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. Clinical Microbiology and Infection. 25(8). 1041.e1–1041.e7. 21 indexed citations
9.
Hameed, H. M. Adnan, Md. Mahmudul Islam, Chiranjibi Chhotaray, et al.. (2018). Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains. Frontiers in Cellular and Infection Microbiology. 8. 114–114. 124 indexed citations
11.
Chhotaray, Chiranjibi, Yaoju Tan, Md. Mahmudul Islam, et al.. (2018). Advances in the development of molecular genetic tools for Mycobacterium tuberculosis. Journal of genetics and genomics. 45(6). 281–297. 15 indexed citations
12.
Makafe, Gaëlle Guiewi, Yuanyuan Cao, Yang Zhang, et al.. (2017). A Cassette Containing Thiostrepton, Gentamicin Resistance Genes, and dif sequences Is Effective in Construction of Recombinant Mycobacteria. Frontiers in Microbiology. 8. 468–468. 5 indexed citations
13.
Islam, Md. Mahmudul, H. M. Adnan Hameed, Chiranjibi Chhotaray, et al.. (2016). Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of genetics and genomics. 44(1). 21–37. 66 indexed citations
14.
Chhotaray, Chiranjibi, Pramoda Kumar Sahoo, Sweta Das, et al.. (2014). Development of twenty-seven genic SSR markers and screening for their association with resistance to Aeromonas hydrophila infection in rohu (Labeo rohita, Hamilton). Biochemical Systematics and Ecology. 58. 85–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026